K.W. STAPLETON

933 total citations
22 papers, 738 citations indexed

About

K.W. STAPLETON is a scholar working on Pulmonary and Respiratory Medicine, Ocean Engineering and Health, Toxicology and Mutagenesis. According to data from OpenAlex, K.W. STAPLETON has authored 22 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Ocean Engineering and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in K.W. STAPLETON's work include Inhalation and Respiratory Drug Delivery (16 papers), Particle Dynamics in Fluid Flows (9 papers) and Air Quality and Health Impacts (3 papers). K.W. STAPLETON is often cited by papers focused on Inhalation and Respiratory Drug Delivery (16 papers), Particle Dynamics in Fluid Flows (9 papers) and Air Quality and Health Impacts (3 papers). K.W. STAPLETON collaborates with scholars based in Canada, United States and Netherlands. K.W. STAPLETON's co-authors include Warren H. Finlay, Hak‐Kim Chan, Igor Gonda, John D. Perry, Kristin E. Day, John R. Dean, Deepshikha Verma, Lian J. Pennings, Thomas Hofmann and Matthew Zimmerman and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Applied Physiology and International Journal of Pharmaceutics.

In The Last Decade

K.W. STAPLETON

21 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.W. STAPLETON Canada 15 587 178 170 88 85 22 738
František Lízal Czechia 16 482 0.8× 211 1.2× 163 1.0× 116 1.3× 46 0.5× 57 659
Wesley DeHaan United States 7 563 1.0× 121 0.7× 103 0.6× 42 0.5× 48 0.6× 19 745
Craig Dunbar United States 14 551 0.9× 142 0.8× 68 0.4× 77 0.9× 69 0.8× 20 672
Árpád Farkas Hungary 19 824 1.4× 217 1.2× 146 0.9× 76 0.9× 161 1.9× 79 1.1k
Laleh Golshahi United States 20 865 1.5× 204 1.1× 75 0.4× 76 0.9× 218 2.6× 50 1.2k
Jakub Elcner Czechia 12 354 0.6× 151 0.8× 121 0.7× 88 1.0× 31 0.4× 32 444
Tanya Church United Kingdom 15 429 0.7× 120 0.7× 64 0.4× 67 0.8× 86 1.0× 36 545
Xiuhua Si United States 11 409 0.7× 126 0.7× 67 0.4× 73 0.8× 56 0.7× 32 541
Stephen W. Stein United States 18 893 1.5× 194 1.1× 82 0.5× 93 1.1× 259 3.0× 35 1.1k
Landon T. Holbrook United States 8 335 0.6× 136 0.8× 72 0.4× 63 0.7× 42 0.5× 12 423

Countries citing papers authored by K.W. STAPLETON

Since Specialization
Citations

This map shows the geographic impact of K.W. STAPLETON's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.W. STAPLETON with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.W. STAPLETON more than expected).

Fields of papers citing papers by K.W. STAPLETON

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.W. STAPLETON. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.W. STAPLETON. The network helps show where K.W. STAPLETON may publish in the future.

Co-authorship network of co-authors of K.W. STAPLETON

This figure shows the co-authorship network connecting the top 25 collaborators of K.W. STAPLETON. A scholar is included among the top collaborators of K.W. STAPLETON based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.W. STAPLETON. K.W. STAPLETON is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
STAPLETON, K.W., et al.. (2025). The Influence of Pressurized Metered Dose Inhaler Actuator Orifice Diameter on Regional Extrathoracic Deposition of Inhaled Epinephrine. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 38(3). 106–117.
2.
Fink, James B. & K.W. STAPLETON. (2024). Nebulizers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 37(3). 140–156. 4 indexed citations
3.
Fukuda, Yoshiyuki, K.W. STAPLETON, & Takayuki Kato. (2022). Progress in spatial resolution of structural analysis by cryo-EM. Microscopy. 72(2). 135–143. 4 indexed citations
4.
Verma, Deepshikha, Lian J. Pennings, Matthew Zimmerman, et al.. (2019). Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections. Journal of Cystic Fibrosis. 18(5). 714–720. 51 indexed citations
5.
STAPLETON, K.W.. (2018). Orally inhaled migraine therapy: Where are we now?. Advanced Drug Delivery Reviews. 133. 131–134. 1 indexed citations
6.
STAPLETON, K.W., et al.. (2013). The potential impact of washing machines on laundry malodour generation. Letters in Applied Microbiology. 56(4). 299–306. 32 indexed citations
7.
Thelin, William R., et al.. (2009). GS-9411: A Potential Aerosol Pharmacotherapy for CF.. A1195–A1195. 4 indexed citations
8.
STAPLETON, K.W., et al.. (2000). On the suitability of k–ε turbulence modeling for aerosol deposition in the mouth and throat: a comparison with experiment. Journal of Aerosol Science. 31(6). 739–749. 259 indexed citations
9.
STAPLETON, K.W., et al.. (1998). Comparisons between Inhaled Fine Particle Fractions and Lung Dose for Nebulized Aerosols. Journal of Aerosol Medicine. 11(s1). S–65. 2 indexed citations
10.
STAPLETON, K.W. & Warren H. Finlay. (1998). Errors in Characterizing Nebulized Particle Size Distributions with Cascade Impactors. Journal of Aerosol Medicine. 11(s1). S–80. 14 indexed citations
11.
Finlay, Warren H., et al.. (1998). Variations in Predicted Regional Lung Deposition of Salbutamol Sulphate Between 19 Nebulizer Types. Journal of Aerosol Medicine. 11(2). 65–80. 25 indexed citations
12.
Finlay, Warren H., et al.. (1997). Errors in regional lung deposition predictions of nebulized salbutamol sulphate due to neglect or partial inclusion of hygroscopic effects. International Journal of Pharmaceutics. 149(1). 63–72. 17 indexed citations
13.
Finlay, Warren H., et al.. (1997). PREDICTING REGIONAL LUNG DOSAGES OF A NEBULIZED SUSPENSION: PULMICORT® (BUDESONIDE). Particulate Science And Technology. 15(3-4). 243–251. 14 indexed citations
14.
Finlay, Warren H., et al.. (1996). On the Use of Computational Fluid Dynamics for Simulating Flow and Particle Deposition in the Human Respiratory Tract. Journal of Aerosol Medicine. 9(3). 329–341. 20 indexed citations
15.
Finlay, Warren H., et al.. (1996). Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling. Journal of Applied Physiology. 81(1). 374–383. 44 indexed citations
16.
Finlay, Warren H., et al.. (1995). The Effect of Ambient Relative Humidity on Regional Dosages Delivered by a Jet Nebulizer. Journal of Aerosol Medicine. 8(4). 363–372. 20 indexed citations
17.
STAPLETON, K.W. & Warren H. Finlay. (1995). Determining solution concentration within aerosol droplets output by jet nebulizers. Journal of Aerosol Science. 26(1). 137–145. 27 indexed citations
18.
Finlay, Warren H., et al.. (1995). An in vitro technique for calculating the regional dosages of drugs delivered by an ultrasonic nebulizer. Journal of Aerosol Science. 26(5). 847–860. 12 indexed citations
19.
Finlay, Warren H. & K.W. STAPLETON. (1995). The effect on regional lung deposition of coupled heat and mass transfer between hygroscopic droplets and their surrounding phase. Journal of Aerosol Science. 26(4). 655–670. 63 indexed citations
20.
STAPLETON, K.W., et al.. (1994). An In Vitro Method for Determining Regional Dosages Delivered by Jet Nebulizers. Journal of Aerosol Medicine. 7(4). 325–344. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by František Lízal Breakdown of academic impact, for papers by Wesley DeHaan Breakdown of academic impact, for papers by Craig Dunbar Breakdown of academic impact, for papers by Árpád Farkas Breakdown of academic impact, for papers by Laleh Golshahi Breakdown of academic impact, for papers by Jakub Elcner Breakdown of academic impact, for papers by Tanya Church Breakdown of academic impact, for papers by Xiuhua Si Breakdown of academic impact, for papers by Stephen W. Stein Breakdown of academic impact, for papers by Landon T. Holbrook
Rankless by CCL
2026